Low antitubercular drug levels in newly infected normal hosts

1. WHO. Global tuberculosis control 2010: TB facts [Internet]. 2011 [cited 2012 Mar 23]. Available from: http://www.who.int/tb/publications/global_report/2010/en/index.htmlSearch in Google Scholar

2. Espinal MA, Kim SJ, Suarez PG, Kam KM, Khomenko AG, Migliori GB, et al. Standard short-course chemotherapy for drug-resistant tuberculosis. JAMA. 2000; 283:2537-45.10.1001/jama.283.19.253710815117Search in Google Scholar

3. Peloquin CA. Therapeutic drug monitoring in the treatment of tuberculosis. Drugs. 2002; 62:2169-83.10.2165/00003495-200262150-0000112381217Open DOISearch in Google Scholar

4. Holland DP, Hamilton CD, Weintrob AC, Engemann JJ, Fortenberry ER, Peloquin CA, et al. Therapeutic drug monitoring of antimycobacterial drugs in patients with both tuberculosis and advanced human immunodeficiency virus infection. Pharmacotherapy. 2009; 29:503-10.10.1592/phco.29.5.50319397460Open DOISearch in Google Scholar

5. Mehta JB, Shantaveerapa H, Byrd RP, Morton SE, Fountain F, Roy TM. Utility of rifampin blood levels in the treatment and follow-up of active pulmonary tuberculosis in patients who were slow to respond to routine directly observed therapy. Chest. 2001; 120: 1520-4.10.1378/chest.120.5.152011713129Open DOISearch in Google Scholar

6. Chideya S, Winston CA, Peloquin CA, Bradford WZ, Hopewell PC, Wells CD, et al. Isoniazid, Rifampin, Ethambutol, and Pyrazinamide pharmacokinetics and treatment outcomes among a predominantly HIVinfected cohort of adults with tuberculosis from Botswana. Clin Infect Dis. 2009; 48:1685-94.10.1086/599040376246119432554Open DOISearch in Google Scholar

7. Heysell SK, Moore JL, Keller SJ, Houpt ER. Therapeutic drug monitoring for slow response to tuberculosis treatment in a state control program, Virginia, USA. Emerg Infect Dis. 2010; 16:1546-53.10.3201/eid1610.100374329439320875279Open DOISearch in Google Scholar

8. McIlleron H, Wash P, Burger A, Norman J, Folb PI, Smith P. Determinants of Rifampin, Isoniazid, Pyrazinamide, and Ethambutol pharmacokinetics in a cohort of tuberculosis patients. Antimicrob Agents Ch. 2006; 50:1170-7.10.1128/AAC.50.4.1170-1177.2006142698116569826Open DOISearch in Google Scholar

9. Jittimanee S, Vorasingha J, Mad-asin W, Nateniyom S, Rienthong S, Varma JK. Tuberculosis in Thailand: epidemiology and program performance, 2001-2005. Int J Infect Dis. 2009; 13:436-42.10.1016/j.ijid.2008.07.02519013094Open DOISearch in Google Scholar

10. Boonsarngsuk V, Tansirichaiya K, Kiatboonsri S. Thai drug-resistant tuberculosis predictive scores. Singapore Med J. 2009; 50:378-84.Search in Google Scholar

11. Ministry of Public Health. The Thai guidelines for tuberculosis control in: Bureau of AIDS TB and STIs, (ed.). Office of National Buddhism Publisher: Bangkok. 2005.Search in Google Scholar

12. Yoshiyama T, Supawitkul S, Kunyanone N, Riengthong D, Yanai H, Abe C, et al. Prevalence of drug-resistant tuberculosis in an HIV endemic area in northern Thailand. Int J Tuberc Lung D. 2001; 5: 32-9.Search in Google Scholar

13. Akksilp S, Wattanaamornkiat W, Kittikraisak W, Nateniyom S, Rienthong S, Sirinak C, et al. Multidrugresistant TB and HIV in Thailand: overlapping, but not independently associated, risk factors. Southeast Asian J Trop Med Public Health. 2009; 40:1000-14.Search in Google Scholar

14. Smith PJ, Van Dyk J, Fredericks A. Determination of rifampicin, isoniazid and pyrazinamide by high performance liquid chromatography after their simultaneous extraction from plasma. Int J Tuberc Lung D. 1999; 3:S325-8.Search in Google Scholar

15. Unsalan S, Sancar M, Bekce B, Clark PM, Karagoz T, Izzettin FV, et al. Therapeutic Monitoring of Isoniazid, Pyrazinamide and Rifampicin in tuberculosis patients using LC. Chromatographia. 2005; 61:595-8.10.1365/s10337-005-0549-0Open DOISearch in Google Scholar

16. Tappero JW, Bradford WZ, Agerton TB, Hopewell P, Reingold AL, Lockman S, et al. Serum concentrations of antimycobacterial drugs in patients with pulmonary tuberculosis in Botswana. Clin Infect Dis. 2005; 41: 461-9.10.1086/43198416028152Open DOISearch in Google Scholar

17. Kimerling ME, Phillips P, Patterson P, Hall M, Robinson CA, Dunlap NE. Low serum antimycobacterial drug levels in non-HIV-infected tuberculosis patients. Chest. 1998; 113:1178-83.10.1378/chest.113.5.11789596291Open DOISearch in Google Scholar